HempMeds – Hemp CBD Oil subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA) is proud to announce that it will be 2015 title sponsor for Hope4Harper. According to reports, the 4th Annual “Run4Hope” event, which is a 1-Mile long Kids’ fun run, will take place on September 12, 2015, at Andy Brown Park East in Coppell.
Hope4Harper has decided to organize this fun race to raise funds for executing research related to disorders like Cyclin Dependent Kinase Like 5, epilepsy, CDKL5 and seizure. Medical Marijuana is known for taking steps that motivate R&D in critical health diseases. HempMeds will work as the exclusive marketing and master distributor company for this event.
In a recent interview, HempMeds’ spokesperson Andrew Hard said that the entire management team’s delighted to become a part of Run4Hope Fun Run & 5K event as its title sponsor. Harper has achieved at the age of five what people cannot achieve in their entire lifetime, and it could be possible through her parents’ love, and the care shown by support network. Her life is a true inspiration for others to do well in negative times and live a meaningful life.
When Harper was just 15 days old, she suffered from Seizures. Her parents roamed all over the country to find a qualified doctor who could tell them what’s happening to her. When Penny and Dustin Howard came across words like “CDKL5” and “no available cure,” they decided to do everything they could to ensure that Harper gets a life she deserves.
CDKL5 is a debilitating and rare seizure disorder that affects a newborn baby in initial few months. Before Harper was found diagnosed with CDKL5, only 300 other people were found suffering from this disease. Since Harper’s case, this number has doubled. CDKL5 leaves a child unable to move, talk or feed himself.
Medical Marijuana Inc (OTCMKTS:MJNA) management looks forward to spreading awareness about CDKL5 by successfully organizing this event.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of USmarketsDaily.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: